Abeona Therapeutics Inc. Common Stock

ABEO XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

320M

Short interest (May 15)

25.4%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.79%

↓ 2.4%

Available Shares

↑ 21.2%

Price Chart

Company Overview

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0000318306

Asset Type: CS

Market Data

Market Cap: $324,302,369

Employees: 226

Status: Active

Short Interest

Current Borrow Fee 0.79%

Range: 0.77% - 0.80%

Available Shares 4M

Range: 3.8M - 4.1M

Recent Changes

Fee Change: ↑ 0.1%

Available Change: ↓ 2.4%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime